Lates News

On May 8th, Roche Pharmaceutical's brand new biopharmaceutical production base investment project officially started in Zhangjiang, Shanghai, China. The project has an investment of 2.04 billion yuan, and the initial products are mainly for the localized production of drugs for the treatment of retinal diseases, accelerating to meet the demand of Chinese patients for high-quality drugs.